AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 14,560
-392 (-2.62%)
Apr 21, 2026, 5:02 PM GMT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 231.9 billion as of April 21, 2026. Its market cap has increased by 48.72% in one year.
Market Cap
231.90B
Enterprise Value
249.76B
Revenue
43.64B
Ranking
n/a
PE Ratio
30.77
Stock Price
14,560.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 231.90B, an increase of 4,996.34%. That is a compound annual growth rate of 12.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 231.90B | 8.44% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 85.63B |
| Haleon | 31.94B |
| Smith & Nephew | 10.83B |
| Convatec Group | 4.70B |
| Hikma Pharmaceuticals | 2.98B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.77B |
| Oxford Nanopore Technologies | 1.22B |